Malin Fagerås

2.1k total citations · 1 hit paper
33 papers, 941 citations indexed

About

Malin Fagerås is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Malin Fagerås has authored 33 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 19 papers in Physiology and 3 papers in Epidemiology. Recurrent topics in Malin Fagerås's work include Asthma and respiratory diseases (19 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Respiratory and Cough-Related Research (9 papers). Malin Fagerås is often cited by papers focused on Asthma and respiratory diseases (19 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Respiratory and Cough-Related Research (9 papers). Malin Fagerås collaborates with scholars based in Sweden, United Kingdom and United States. Malin Fagerås's co-authors include Mona Bafadhel, Stefan Peterson, Stephen I. Rennard, Peter M.A. Calverley, Kai Richter, Catrin Furuhjelm, Karel Duchén, Karin Fälth‐Magnusson, Kristina Warstedt and Ian Pavord and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Malin Fagerås

28 papers receiving 926 citations

Hit Papers

Predictors of exacerbation risk and response to budesonid... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
    2018 302 citations Mona Bafadhel, Stefan Peterson et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malin Fagerås Sweden 12 656 626 125 115 96 33 941
Sunna Thorsteinsdóttir Denmark 6 369 0.6× 213 0.3× 98 0.8× 169 1.5× 57 0.6× 8 751
Helene M. Wolsk Denmark 10 439 0.7× 272 0.4× 69 0.6× 193 1.7× 71 0.7× 11 942
Teija Dunder Finland 14 230 0.4× 293 0.5× 92 0.7× 83 0.7× 29 0.3× 28 572
Brooke Schuemann United States 9 506 0.8× 317 0.5× 27 0.2× 88 0.8× 80 0.8× 13 709
Tine Marie Pedersen Denmark 6 324 0.5× 216 0.3× 43 0.3× 171 1.5× 51 0.5× 10 709
M Wjst Germany 11 543 0.8× 182 0.3× 186 1.5× 46 0.4× 111 1.2× 17 763
C. Bodner United Kingdom 9 371 0.6× 153 0.2× 142 1.1× 55 0.5× 59 0.6× 10 585
Luis Miguel Franchi United States 7 270 0.4× 273 0.4× 56 0.4× 49 0.4× 20 0.2× 8 470
Antonela Martínez-Torres Spain 9 230 0.4× 166 0.3× 95 0.8× 20 0.2× 29 0.3× 11 441
Henrik Wegener Hallas Denmark 5 255 0.4× 189 0.3× 28 0.2× 51 0.4× 23 0.2× 7 435

Countries citing papers authored by Malin Fagerås

Since Specialization
Citations

This map shows the geographic impact of Malin Fagerås's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malin Fagerås with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malin Fagerås more than expected).

Fields of papers citing papers by Malin Fagerås

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malin Fagerås. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malin Fagerås. The network helps show where Malin Fagerås may publish in the future.

Co-authorship network of co-authors of Malin Fagerås

This figure shows the co-authorship network connecting the top 25 collaborators of Malin Fagerås. A scholar is included among the top collaborators of Malin Fagerås based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malin Fagerås. Malin Fagerås is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fagerås, Malin, et al.. (2025). Current Smoking and Pharmacological Treatment Responses in Chronic Obstructive Pulmonary Disease: Not Clear-Cut. American Journal of Respiratory and Critical Care Medicine. 211(11). 2223–2224. 1 indexed citations
2.
Maslova, Ekaterina, et al.. (2025). 304. Global Incidence of Viral Lower Respiratory Tract Disease (LRTD) Episodes and Hospitalizations (2010–2021). Open Forum Infectious Diseases. 12(Supplement_1).
3.
4.
Nordon, Clémentine, Malin Fagerås, Hana Müllerová, et al.. (2024). Exacerbation and mortality in COPD patients on triple inhaler and at high exacerbation risk. Epidemiology. PA1287–PA1287.
5.
Janssens, Wim, Clémentine Nordon, George Bell, et al.. (2024). Characteristics of exacerbating COPD patients with productive cough and on inhaled triple therapy, by smoking status: a real-world multi-country study. Epidemiology. PA1288–PA1288. 1 indexed citations
6.
7.
8.
Casaburi, Richard, Debora Merrill, Thomas E. Dolmage, et al.. (2022). Endurance Time During Constant Work Rate Cycle Ergometry in COPD: Development of an Integrated Database From Interventional Studies. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 9(4). 520–537. 1 indexed citations
9.
Barnes, Peter J., Gary P. Anderson, Malin Fagerås, & Maria G. Belvisi. (2021). Chronic lung diseases: prospects for regeneration and repair. European Respiratory Review. 30(159). 200213–200213. 19 indexed citations
10.
Kraft, Monica, Guy Brusselle, J. Mark FitzGerald, et al.. (2021). Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma. European Respiratory Journal. 58(6). 2100413–2100413. 43 indexed citations
11.
Harrison, Tim, Ian Pavord, James D. Chalmers, et al.. (2020). Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design. ERJ Open Research. 6(2). 333–2019. 4 indexed citations
12.
Jauhiainen, Alexandra, Lieke E.J.M. Scheepers, Anne L. Fuhlbrigge, et al.. (2020). Impact of season and geography on CompEx Asthma: a composite end-point for exacerbations. ERJ Open Research. 6(4). 246–2020. 3 indexed citations
13.
14.
Bafadhel, Mona, Dave Singh, Christine Jenkins, et al.. (2020). Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis. Respiratory Research. 21(1). 17–17. 17 indexed citations
15.
Müllerová, Hana, Mark T. Dransfield, Byron Thomashow, et al.. (2019). Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test. American Journal of Respiratory and Critical Care Medicine. 201(9). 1058–1067. 4 indexed citations
16.
Fuhlbrigge, Anne L., Tim Harrison, Malin Fagerås, et al.. (2019). An Investigation of Geographic Influence on CompEx, a Surrogate Endpoint for Severe Asthma Exacerbations. A1298–A1298. 1 indexed citations
17.
Menzies‐Gow, Andrew, Mona Bafadhel, William W. Busse, et al.. (2019). An expert consensus framework for asthma remission as a treatment goal. Journal of Allergy and Clinical Immunology. 145(3). 757–765. 225 indexed citations
18.
Bafadhel, Mona, Stefan Peterson, Peter M.A. Calverley, et al.. (2018). Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. The Lancet Respiratory Medicine. 6(2). 117–126. 302 indexed citations breakdown →
19.
Fagerås, Malin, Sara Tomičić, Tiia Voor, Bengt Björkstén, & Maria C. Jenmalm. (2011). Slow Salivary Secretory IgA Maturation May Relate to Low Microbial Pressure and Allergic Symptoms in Sensitized Children. Pediatric Research. 70(6). 572–577. 44 indexed citations
20.
Warstedt, Kristina, Catrin Furuhjelm, Karel Duchén, Karin Fälth‐Magnusson, & Malin Fagerås. (2009). The Effects of Omega-3 Fatty Acid Supplementation in Pregnancy on Maternal Eicosanoid, Cytokine, and Chemokine Secretion. Pediatric Research. 66(2). 212–217. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunna Thorsteinsdóttir Breakdown of academic impact, for papers by Helene M. Wolsk Breakdown of academic impact, for papers by Teija Dunder Breakdown of academic impact, for papers by Brooke Schuemann Breakdown of academic impact, for papers by Tine Marie Pedersen Breakdown of academic impact, for papers by M Wjst Breakdown of academic impact, for papers by C. Bodner Breakdown of academic impact, for papers by Luis Miguel Franchi Breakdown of academic impact, for papers by Antonela Martínez-Torres Breakdown of academic impact, for papers by Henrik Wegener Hallas
Rankless by CCL
2026